
Professor
Department of Microbiology and Immunology
Primary Thematic Area
Secondary Thematic Area
Research Summary
Replication of RNA Viruses and Vaccine Development
+1 415 514-4404
We study molecular processes that lead to the replication of RNA viruses. We developed an heterologous system in which to biochemically dissect mechanisms of virus synthesis. Microinjection of poliovirus RNA into Xenopus laevis oocytes initiates a complete and authentic replication cycle which yields a high level of infectious viruses, but only if poliovirus RNA is co-injected with factors present in HeLa cells. Two additional mammalian cell factors are required for viral replication in oocytes, one involved in initiation of translation, and the other in RNA synthesis. Thus, microinjection in oocytes can be used to identify and further analyze the function of viral and cellular factors and to biochemically dissect the mechanism of initiation of poliovirus translation and RNA synthesis. Recently, we discovered that the virus overlaps translation and replication cis-acting signals as a strategy to control the use of the RNA template for viral processes that require a concerted action like translation and RNA replication.
We also study the mechanism of immunity to RNA viruses with the hope of developing safe and efficacious vaccines. Protective immunity against many infectious diseases and effective immunotherapies for cancer may require priming of both humoral and cellular immune responses. Recombinant viruses represent a particularly promising approach because they can replicate in a variety of host cell types and induce both humoral and cell-mediated immune responses. We have engineered poliovirus to express antigens derived from influenza virus, rotavirus, Vibrio cholerae, HBV, SIV, and HIV. Mice and monkeys infected with recombinant viruses raised antibody response against the foreign proteins. Importantly, vaccination of mice with recombinant poliovirus elicits an antigen specific CTL response that protects 100% of the immunized animals from challenge with a highly aggressive melanoma cell line. Thus, poliovirus vectors may provide an effective system to induce both humoral and cellular immune responses systemically and also at local mucosal sites.
We also study the mechanism of immunity to RNA viruses with the hope of developing safe and efficacious vaccines. Protective immunity against many infectious diseases and effective immunotherapies for cancer may require priming of both humoral and cellular immune responses. Recombinant viruses represent a particularly promising approach because they can replicate in a variety of host cell types and induce both humoral and cell-mediated immune responses. We have engineered poliovirus to express antigens derived from influenza virus, rotavirus, Vibrio cholerae, HBV, SIV, and HIV. Mice and monkeys infected with recombinant viruses raised antibody response against the foreign proteins. Importantly, vaccination of mice with recombinant poliovirus elicits an antigen specific CTL response that protects 100% of the immunized animals from challenge with a highly aggressive melanoma cell line. Thus, poliovirus vectors may provide an effective system to induce both humoral and cellular immune responses systemically and also at local mucosal sites.
Websites
Publications
Now you see me, now you don't: What and how viral RNAs are detected by cytoplasmic pattern-recognition receptors.
Molecular cell
A tradeoff between enterovirus A71 particle stability and cell entry.
Nature communications
Reconsidering life history theory amid infectious diseases.
Trends in ecology & evolution
Fluorogenic reporter enables identification of compounds that inhibit SARS-CoV-2.
Nature microbiology
SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming.
Cell
Is Aging an Inevitable Characteristic of Organic Life or an Evolutionary Adaptation?
Biochemistry. Biokhimiia
Could aging evolve as a pathogen control strategy?
Trends in ecology & evolution
A defective viral genome strategy elicits broad protective immunity against respiratory viruses.
Cell
Author Correction: Cotranslational prolyl hydroxylation is essential for flavivirus biogenesis.
Nature
Examining the interplay between face mask usage, asymptomatic transmission, and social distancing on the spread of COVID-19.
Scientific reports
Epidemics as an adaptive driving force determining lifespan setpoints.
Proceedings of the National Academy of Sciences of the United States of America
Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence.
Cell host & microbe
Enterovirus pathogenesis requires the host methyltransferase SETD3.
Nature microbiology
A Viral Protein Restricts Drosophila RNAi Immunity by Regulating Argonaute Activity and Stability.
Cell host & microbe
Mechanisms and Concepts in RNA Virus Population Dynamics and Evolution.
Annual review of virology
Hsp90 shapes protein and RNA evolution to balance trade-offs between protein stability and aggregation.
Nature communications
Mapping the Evolutionary Potential of RNA Viruses.
Cell host & microbe
The Diversity, Structure, and Function of Heritable Adaptive Immunity Sequences in the Aedes aegypti Genome.
Current biology : CB
Poliovirus intrahost evolution is required to overcome tissue-specific innate immune responses.
Nature communications
Circulating Immune Cells Mediate a Systemic RNAi-Based Adaptive Antiviral Response in Drosophila.
Cell
Editorial overview: Viral pathogenesis: Strategies for virus survival - Acute versus persistent infections.
Current opinion in virology
Viral polymerases.
Virus research
Characterization of Viral Populations by Using Circular Sequencing.
Journal of virology
RNA Recombination Enhances Adaptability and Is Required for Virus Spread and Virulence.
Cell host & microbe
Viral quasispecies.
Virology
Use of host-like peptide motifs in viral proteins is a prevalent strategy in host-virus interactions.
Cell reports
Rationalizing the development of live attenuated virus vaccines.
Nature biotechnology